These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34088654)

  • 1. Ocular cicatricial pemphigoid: Methotrexate as an initial treatment?
    Smichowski AM; Caputo VD; Romeo C; Rivero E; Morales NS; Casado G
    Reumatol Clin (Engl Ed); 2022 Jan; 18(1):30-32. PubMed ID: 34088654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular Cicatricial Pemphigoid: Methotrexate as an Initial Treatment?
    Smichowski AM; Caputo VD; Romeo C; Rivero E; Morales NS; Casado G
    Reumatol Clin (Engl Ed); 2021 Jan; ():. PubMed ID: 33454207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid.
    Miserocchi E; Baltatzis S; Roque MR; Ahmed AR; Foster CS
    Ophthalmology; 2002 Jan; 109(1):111-8. PubMed ID: 11772589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ocular Cicatricial Pemphigoid - a Retrospective Study].
    Szabó E; Palos M; Skalická P
    Cesk Slov Oftalmol; 2016 Feb; 72(1):283-92. PubMed ID: 27041284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate therapy for ocular cicatricial pemphigoid.
    McCluskey P; Chang JH; Singh R; Wakefield D
    Ophthalmology; 2004 Apr; 111(4):796-801. PubMed ID: 15051215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate as a treatment in ocular cicatricial moderate pemphigoid.
    Hervás Ontiveros A; Salom D; España Gregori E; Jiménez Herrero E; Díaz-Llopis M
    Arch Soc Esp Oftalmol; 2014 Nov; 89(11):447-9. PubMed ID: 24359845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ocular cicatricial pemphigoid. Retrospective analysis of risk factors and complications].
    Messmer EM; Hintschich CR; Partscht K; Messer G; Kampik A
    Ophthalmologe; 2000 Feb; 97(2):113-20. PubMed ID: 10734737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes.
    Saw VP; Dart JK; Rauz S; Ramsay A; Bunce C; Xing W; Maddison PG; Phillips M
    Ophthalmology; 2008 Feb; 115(2):253-261.e1. PubMed ID: 17655931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current medical treatment of ocular mucous membrane pemphigoid.
    Sobolewska B; Deuter C; Zierhut M
    Ocul Surf; 2013 Oct; 11(4):259-66. PubMed ID: 24112229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostics and pharmacological treatment of ocular cicatrical pemphigoid].
    Brydak-Godowska J; Moneta-Wielgoś J; Pauk-Domańska M; Dróbecka-Brydak E; Samsel A; Kecik M; Kowalewski C; Mackiewicz W; Kecik D
    Klin Oczna; 2005; 107(10-12):725-7. PubMed ID: 16619831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies.
    Letko E; Miserocchi E; Daoud YJ; Christen W; Foster CS; Ahmed AR
    Clin Immunol; 2004 Jun; 111(3):303-10. PubMed ID: 15183151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Systemic treatment of ocular cicatricial pemphigoid].
    Juri MC; Fernández Romero DS; Devoto MH; Georgiett D; Zárate JO; Malbrán A
    Medicina (B Aires); 2012; 72(2):103-8. PubMed ID: 22522849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Characteristics and Outcomes of Ocular Cicatricial Pemphigoid: A Cohort Study and Literature Review.
    Fremont F; Pelissier-Suarez C; Fournié P; Porterie M; Thevenin A; Astudillo L; Paricaud K; Gualino V; Soler V; Pugnet G
    Cornea; 2019 Nov; 38(11):1406-1411. PubMed ID: 31356420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive therapy in ocular cicatricial pemphigoid.
    Mondino BJ; Brown SI
    Am J Ophthalmol; 1983 Oct; 96(4):453-9. PubMed ID: 6353928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Approach to Ocular Cicatricial Pemphigoid.
    Çiftçi MD; Korkmaz İ; Palamar M; Yaman B; Eğrilmez S; Yağcı A; Akalın T; Barut Selver Ö
    Turk J Ophthalmol; 2023 Apr; 53(2):79-84. PubMed ID: 37089009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular cicatricial pemphigoid.
    Tauber J
    Ophthalmology; 2008 Sep; 115(9):1639-40; author reply 1640-1. PubMed ID: 18762085
    [No Abstract]   [Full Text] [Related]  

  • 17. Rituximab in the treatment of ocular cicatricial pemphigoid: a retrospective cohort study.
    You C; Lamba N; Lasave AF; Ma L; Diaz MH; Foster CS
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1221-1228. PubMed ID: 28154932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and adverse reactions of methotrexate in the treatment of ocular cicatricial pemphigoid: A case series study.
    Shi Y; Xie C; He Y; Liu H; Zhu B; Zhu J
    Medicine (Baltimore); 2018 Sep; 97(38):e12338. PubMed ID: 30235689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular Cicatricial Pemphigoid: Camouflaged as Persistent Conjunctivitis.
    Mughal JU; Muhammad AJ; Erum U
    J Coll Physicians Surg Pak; 2019 Jun; 29(6):S34-S36. PubMed ID: 31142415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular cicatricial pemphigoid.
    Sanfilippo P; Lee G
    Clin Exp Optom; 2003 Jan; 86(1):47-50. PubMed ID: 12568651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.